SINOMED(SH:688108) Shang Hai Zheng Quan Bao·2026-01-19 19:27Core Viewpoint - The announcement details the results of the second vesting period of the first grant under the 2022 Restricted Stock Incentive Plan of Sainuo Medical Technology Co., Ltd, including the listing and circulation of shares. Group 1: Stock Listing and Circulation - The type of stock being listed is equity incentive shares, with a total of 1,904,000 shares to be listed [2][3] - The listing date for these shares is set for January 22, 2026 [4][12] Group 2: Decision-Making Process and Disclosure - The decision-making process for the stock vesting was approved during the board meeting on April 27, 2022, with independent directors providing clear consent [5] - The company conducted a public notice period for the proposed incentive objects from April 29 to May 12, 2022, with no objections received [6] Group 3: Shareholder Meeting and Approvals - The 2021 annual shareholder meeting on May 20, 2022, approved the incentive plan and related proposals, with results disclosed on May 21, 2022 [7] Group 4: Stock Source and Vesting Details - The shares for this vesting are sourced from the company's directed issuance of A-share common stock to incentive objects, with a total of 7 individuals involved [12] - The shares are subject to transfer restrictions, including limits on annual transfers and conditions for selling within specified timeframes [12] Group 5: Financial Impact - Following the vesting, the company's total share capital increased from 416,048,000 shares to 417,952,000 shares, with the new shares representing approximately 0.4576% of the total before vesting [15]